AstraZeneca will rename the COVID vaccine to Vaxzevria in Australia

AstraZeneca will rename the COVID vaccine to Vaxzevria in Australia

The AstraZeneca Covid vaccine is set to go through a rebrand.

The jab was initially called COVID-19 Vaccine AstraZeneca in Australia however will soon be renamed Vaxzevria, which is the thing that it’s known as in Europe.

The change is being made to make it simpler for Australians who have gotten the vaccine to travel and have their vaccination status perceived overseas.

“This minor difference, which will soon disappear, may have created misperceptions that the vaccine is not the same,” the pharmaceutical giant said in a statement.

“For vaccines produced in our global supply chain that are using the original name Covid-19 Vaccine AstraZeneca, we are currently in the process of registering the trade name Vaxzevria, which is used in many other markets, including the EU.

“This will facilitate travel for people who have received AstraZeneca’s vaccine from anywhere in the world.”

The change will likewise guarantee shoppers don’t confuse the AstraZeneca organization brand with its individual pharmaceutical products.

The highly-effective AstraZeneca hit has formed the backbone of Australia’s vaccine rollout, with a huge number of dosages being made every month at CSL’s Melbourne factory.

In excess of 750 million dosages of the jab have so far been distributed around the world.

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Chicago Headlines journalist was involved in the writing and production of this article.

Share This Post

Post Comment